496 results on '"Zhan, Xianquan"'
Search Results
2. Big data for neuroscience in the context of predictive, preventive, and personalized medicine
3. Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches
4. Body fluid multiomics in 3PM-guided ischemic stroke management: health risk assessment, targeted protection against health-to-disease transition, and cost-effective personalized approach are envisaged
5. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach
6. Immune-related gene methylation prognostic instrument for stratification and targeted treatment of ovarian cancer patients toward advanced 3PM approach
7. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine
8. Clinically relevant stratification of lung squamous carcinoma patients based on ubiquitinated proteasome genes for 3P medical approach
9. Nitroproteomics is instrumental for stratification and targeted treatments of astrocytoma patients: expert recommendations for advanced 3PM approach with improved individual outcomes
10. A Powerful Paradigm: Predictive, Preventive, and Personalized Medicine with Multiomics of Human Pituitary Adenomas
11. Personalized Drug Therapy: Innovative Concept Guided With Proteoformics
12. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach
13. Ubiquitinomics revealed disease- and stage-specific patterns relevant for the 3PM approach in human sigmoid colon cancers
14. Growth hormone proteoformics atlas created to promote predictive, preventive, and personalized approach in overall management of pituitary neuroendocrine tumors
15. Innovating the Concept and Practice of Two-Dimensional Gel Electrophoresis in the Analysis of Proteomes at the Proteoform Level
16. DNA and histone modifications as potent diagnostic and therapeutic targets to advance non-small cell lung cancer management from the perspective of 3P medicine
17. A Powerful Paradigm: Predictive, Preventive, and Personalized Medicine with Multiomics of Human Pituitary Adenomas
18. Tangled quest of post-COVID-19 infection-caused neuropathology and what 3P nano-bio-medicine can solve?
19. Comprehensive analysis of spliceosome genes and their mutants across 27 cancer types in 9070 patients: clinically relevant outcomes in the context of 3P medicine
20. Muti-omics integration analysis revealed molecular network alterations in human nonfunctional pituitary neuroendocrine tumors in the framework of 3P medicine
21. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine
22. Integrated genomic analysis of proteasome alterations across 11,057 patients with 33 cancer types: clinically relevant outcomes in framework of 3P medicine
23. Mass spectrometry-based proteomics analyses of post-translational modifications and proteoforms in human pituitary adenomas
24. The Use of Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) to Study Ivermectin-Mediated Molecular Pathway Changes in Human Ovarian Cancer Cells
25. Human growth hormone proteoform pattern changes in pituitary adenomas: Potential biomarkers for 3P medical approaches
26. Introductory Chapter: Metabolomics
27. Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine
28. Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine
29. Integration of quantitative phosphoproteomics and transcriptomics revealed phosphorylation-mediated molecular events as useful tools for a potential patient stratification and personalized treatment of human nonfunctional pituitary adenomas
30. Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes
31. Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas
32. Editorial: Advances in approaches for function-preserving gastric cancer surgery
33. Mass spectrometry analysis of phosphotyrosine‐containing proteins.
34. A Review on Innovating the Concept and Practice of Two-Dimensional Gel Electrophoresis in the Analysis of Proteomes at the Proteoform Level
35. The Anti-Cancer Effects of Anti-Parasite Drug Ivermectin in Ovarian Cancer
36. Current Topics in Medicine and Medical Research Vol. 11
37. Abnormal Ubiquitination of Ubiquitin-Proteasome System in Lung Squamous Cell Carcinomas
38. Introductory Chapter: Proteoforms
39. Prolactin Proteoform Pattern Changed in Human Pituitary Adenoma Relative to Control Pituitary Tissues
40. Mitochondrial Proteomic and Molecular Network Alterations in Human Ovarian Cancers
41. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application
42. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes
43. Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
44. TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas
45. Identification of clinical trait–related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer
46. Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics
47. The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
48. Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry
49. Quantitative Analysis of the Human Ovarian Carcinoma Mitochondrial Phosphoproteome
50. Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.